Metraipolis › archive › dc_7a6fcb02cae8

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy — Europe PMC PMID:41808243

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41808243
DOI
10.1177/03008916251408279
License (as archived)
solo-consultazione
Archived
2026-11-04T21:20:23.265Z
SHA-256 of the archived text
1e335a072fdab51a41e9c7460c6b62c042685ef85b2a089cc012fe1db11616d8
Stable URL of this page
https://metraipolis.com/documento/dc_7a6fcb02cae8

How to cite

The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy — Europe PMC PMID:41808243 — Europe PMC (en), https://europepmc.org/article/MED/41808243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7a6fcb02cae8 (Metraipolis archive dc_7a6fcb02cae8, sha256 1e335a072fdab51a41e9c7460c6b62c042685ef85b2a089cc012fe1db11616d8)
BibTeX
@misc{dc7a6fcb02cae8,
  title = {The clinical usefulness of knowing CHRNA5 polymorphism genotype: paving the way for personalized therapy — Europe PMC PMID:41808243},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41808243},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7a6fcb02cae8; sha256 1e335a072fdab51a41e9c7460c6b62c042685ef85b2a089cc012fe1db11616d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41808243. Agents can read the archived copy with the MCP tool read_document.